Marvell Technology Targets Up to $90B Revenue by 2031 as AI Demand Accelerates

At its 2026 Investor Day, Marvell raised its fiscal 2028 revenue outlook and projected annual revenue of $70 billion to $90 billion by fiscal 2031. The company cited AI infrastructure demand for connectivity, custom silicon and optical technologies as drivers of its long-term growth plan.

Analysis

The key underwriting question is whether the 2031 ambition represents durable, customer-backed program wins or an extrapolation of today’s AI infrastructure spending. A wide revenue range increases execution optionality but also leaves substantial room for the market to discount the out-year case; the nearer-term fiscal 2028 revision is more price-relevant than the 2031 endpoint. The main second-order risk is that hyperscalers’ custom-silicon demand benefits Marvell while also strengthening customers’ leverage and internal design capabilities. Competition from Broadcom and in-house silicon programs could pressure future program economics; optical and connectivity demand may broaden the opportunity, but adoption timing and attach rates need evidence.

Near term, the announcement can support sentiment, but the 1–3 month test is whether reported results, customer wins and management’s segment-level bridge substantiate the revised outlook. Over 6–18 months, a pause in hyperscaler capex, delayed deployments, or a shift toward fewer, larger custom-chip programs would challenge the growth path. Treat the long-range projection as company guidance, not independently verified demand. Without the size of the fiscal 2028 increase, valuation context, and program-level visibility, the risk/reward of chasing MRVL is unclear.

Key Decisions for Investors

• Do not chase solely on the 2031 headline. Reassess after reviewing the exact fiscal 2028 revenue revision and the assumptions behind the 2031 range, including customer concentration and contribution by custom silicon, connectivity and optical products.
• Watch MRVL’s next earnings and disclosures for order conversion, program ramps, customer concentration, and any change in the near-term outlook. A failure to sustain the raised fiscal 2028 trajectory would weaken the thesis; confirmed ramps would make a staged long more defensible.
• For relative-value exposure, compare MRVL with Broadcom after checking valuation and business-mix data; do not assume MRVL’s growth translates into superior returns without evidence on program economics and execution.
• Treat any slowdown or deferral in hyperscaler AI capital spending, material program delays, or a narrowing of management’s outlook as thesis-falsifying signals; revisit exposure rather than relying on the long-dated revenue ambition.